Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Report

Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Nov 24, 2019
  • PAGES：171
  • REPORT CODE：GMM393035
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.9% during the forecast period.

    This report presents the market size and development trends by detailing the Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs industry and will help you to build a panoramic view of the industrial development.

    Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market, By Type:

    • Preface

    • Eluxadoline

    • Alosetron

    • Rifaximin

    • Loperamide

    • Diphenoxylate + Atropine

    • Dicyclomine and Hyoscyamine

    Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market, By Application:

    • Hospitals

    • Clinics

    • Others

    Some of the leading players are as follows:

    • Astellas Pharmaceuticals

    • AstraZenenca

    • Allergan Ltd

    • Pfizer

    • Actavis

    • GlaxoSmithKline

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market: Technology Type Analysis

    • 4.1 Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Preface

      • 4.3.2 Eluxadoline

      • 4.3.3 Alosetron

      • 4.3.4 Rifaximin

      • 4.3.5 Loperamide

      • 4.3.6 Diphenoxylate + Atropine

      • 4.3.7 Dicyclomine and Hyoscyamine

    5 Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market: Product Analysis

    • 5.1 Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Product Market Share Analysis, 2018 & 2026

    • 5.2 Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market: Application Analysis

    • 6.1 Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Application Market Share Analysis, 2018 & 2026

    • 6.2 Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Hospitals

      • 6.3.2 Clinics

      • 6.3.3 Others

    7 Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market: Regional Analysis

    • 7.1 Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Regional Market Share Analysis, 2018 & 2026

    • 7.2 Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Astellas Pharmaceuticals

      • 9.1.1 Astellas Pharmaceuticals Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 AstraZenenca

      • 9.2.1 AstraZenenca Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Allergan Ltd

      • 9.3.1 Allergan Ltd Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Pfizer

      • 9.4.1 Pfizer Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Actavis

      • 9.5.1 Actavis Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 GlaxoSmithKline

      • 9.6.1 GlaxoSmithKline Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

     

    The List of Tables and Figures (Totals 76 Figures and 129 Tables)

    • Figure Preface Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, 2015 - 2026 (USD Million)

    • Figure Eluxadoline Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, 2015 - 2026 (USD Million)

    • Figure Alosetron Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, 2015 - 2026 (USD Million)

    • Figure Rifaximin Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, 2015 - 2026 (USD Million)

    • Figure Loperamide Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, 2015 - 2026 (USD Million)

    • Figure Diphenoxylate + Atropine Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, 2015 - 2026 (USD Million)

    • Figure Dicyclomine and Hyoscyamine Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, 2015 - 2026 (USD Million)

    • Figure Hospitals market, 2015 - 2026 (USD Million)

    • Figure Clinics market, 2015 - 2026 (USD Million)

    • Figure Others market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by country, 2015 - 2026 (USD Million)

    • Table North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Canada Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Canada Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by country, 2015 - 2026 (USD Million)

    • Table Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Germany Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Germany Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table France Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table France Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Italy Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Italy Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Spain Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Spain Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table China Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table China Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Japan Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Japan Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table India Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table India Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table MEA Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by country, 2015 - 2026 (USD Million)

    • Table MEA Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table MEA Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table MEA Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Astellas Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table AstraZenenca Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Allergan Ltd Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Actavis Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US